Connect with us

Hi, what are you looking for?

Please enter CoinGecko Free Api Key to get this plugin works.

Investing News

Should Governments Fund Research?

Jeffrey Miron and Jacob Winter

The Trump administration sparked controversy this month by reducing grant funding from the National Institutes of Health. The move, currently blocked by a judge, caps the percentage of grant funds that can be used for indirect costs at 15 percent.

There are legitimate debates about a universal cap on funding for indirect costs, as well as about President Trump’s wrecking-ball approach to reforming government.

But it is also worth asking whether governments should fund research at all.

In a previous piece, we argued they should not. Read it here.

You May Also Like

Investing News

Investor Insight For investors with an eye on mining stocks, New Murchison Gold (ASX:NMG) presents a unique opportunity. The company’s shallow, high-grade Crown Prince...

Investing News

Mike Fox As a former public defender, my clients often faced an impossible choice: plead guilty to a crime they knew they didn’t commit...

Finance News

Shares of GameStop and MicroStrategy were on the rise Monday after Ryan Cohen, CEO of the video game retailer, posted a photo with Michael Saylor, co-founder and chairman...

Investing News

Tad DeHaven A 2011 poll taken during the Obama administration found that 60 percent of those surveyed believed that the federal budget could be...



Disclaimer: financehightech.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.